Cargando…
Novaferon, treatment in COVID-19 patients
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688290/ https://www.ncbi.nlm.nih.gov/pubmed/33248244 http://dx.doi.org/10.1016/j.ijid.2020.11.180 |
| _version_ | 1783613677956497408 |
|---|---|
| author | Janapala, Rajesh Naidu Patel, Jigar Belfaqeeh, Omar Alhashmi, Abdulla Pourmand, Ali |
| author_facet | Janapala, Rajesh Naidu Patel, Jigar Belfaqeeh, Omar Alhashmi, Abdulla Pourmand, Ali |
| author_sort | Janapala, Rajesh Naidu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7688290 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76882902020-11-27 Novaferon, treatment in COVID-19 patients Janapala, Rajesh Naidu Patel, Jigar Belfaqeeh, Omar Alhashmi, Abdulla Pourmand, Ali Int J Infect Dis Letter to the Editor The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-02 2020-11-25 /pmc/articles/PMC7688290/ /pubmed/33248244 http://dx.doi.org/10.1016/j.ijid.2020.11.180 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Janapala, Rajesh Naidu Patel, Jigar Belfaqeeh, Omar Alhashmi, Abdulla Pourmand, Ali Novaferon, treatment in COVID-19 patients |
| title | Novaferon, treatment in COVID-19 patients |
| title_full | Novaferon, treatment in COVID-19 patients |
| title_fullStr | Novaferon, treatment in COVID-19 patients |
| title_full_unstemmed | Novaferon, treatment in COVID-19 patients |
| title_short | Novaferon, treatment in COVID-19 patients |
| title_sort | novaferon, treatment in covid-19 patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688290/ https://www.ncbi.nlm.nih.gov/pubmed/33248244 http://dx.doi.org/10.1016/j.ijid.2020.11.180 |
| work_keys_str_mv | AT janapalarajeshnaidu novaferontreatmentincovid19patients AT pateljigar novaferontreatmentincovid19patients AT belfaqeehomar novaferontreatmentincovid19patients AT alhashmiabdulla novaferontreatmentincovid19patients AT pourmandali novaferontreatmentincovid19patients |